Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)

OBJECTIVE: To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns <28 weeks. METHODS: We performed a secondary analysis of the multi-center PDA-TOLERATE trial (NCT01958320). Infants with moderate-to-large PDAs were randomized 1:1 at 8.1±2.1 days to eit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Perinatol
Autors principals: Liebowitz, Melissa, Kaempf, Joseph, Erdeve, Omer, Bulbul, Ali, Håkansson, Stellan, Lindqvist, Johanna, Farooqi, Aijaz, Katheria, Anup, Sauberan, Jason, Singh, Jaideep, Nelson, Kelly, Wickremasinghe, Andrea, Dong, Lawrence, Hassinger, Denise C., Aucott, Susan W., Hayashi, Madoka, Heuchan, Anne Marie, Carey, William A., Derrick, Matthew, Wolf, Ilene Sue, Kimball, Amy, Sankar, Meera, Leone, Tina, Perez, Jorge, Serize, Arturo, Clyman, Ronald I.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://ncbi.nlm.nih.gov/pubmed/30850756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41372-019-0347-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars